Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Increased risk of breast cancer in individuals carrying the TNRC9 rs3803662 C>T polymorphism: a meta-analysis of case-control studies.

Wang Q, Wang NY, Cao XM, Sun X, Shen D, Yuan M, Chen JF.

Genet Mol Res. 2016 Aug 12;15(3). doi: 10.4238/gmr.15038218.

PMID:
27525937
2.

Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects.

Chen MB, Wu XY, Shen W, Wei MX, Li C, Cai B, Tao GQ, Lu PH.

Breast Cancer Res Treat. 2011 Feb;126(1):177-83. doi: 10.1007/s10549-010-1114-6. Epub 2010 Aug 12.

PMID:
20703937
3.

Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L, Li M, Tang J, Wang H, Shen H.

Breast Cancer Res Treat. 2010 Nov;124(1):237-41. doi: 10.1007/s10549-010-0809-z. Epub 2010 Mar 9.

PMID:
20213080
4.

TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.

Li L, Guo G, Wang F, Lv P, Zhu M, Gu Y, Han M, Pei X.

J Cancer Res Ther. 2018;14(Supplement):S208-S212. doi: 10.4103/0973-1482.167611.

5.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
6.

Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.

Tajbakhsh A, Javan FA, Rivandi M, Moezzi A, Abedini S, Asghari M, Farjami Z, Soltanian H, Shandiz FH, Kooshyar MM, Pasdar A.

Mol Biol Rep. 2019 Feb;46(1):805-811. doi: 10.1007/s11033-018-4535-7. Epub 2018 Dec 4.

PMID:
30515698
7.

Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.

Peng L, Li P, Chen J, Yan K, Huo F, Han L, Li C, Tan S, Jiang X.

PLoS One. 2013 Jul 5;8(7):e67738. doi: 10.1371/journal.pone.0067738. Print 2013.

8.

Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.

Mazhar A, Jamil F, Bashir Q, Ahmad MS, Masood M, Tanvir I, Rashid N, Waheed A, Afzal MN, Tariq MA.

Mol Med Rep. 2016 Oct;14(4):3443-51. doi: 10.3892/mmr.2016.5633. Epub 2016 Aug 18.

PMID:
27572905
9.

Association of single nucleotide polymorphism rs3803662 with the risk of breast cancer.

Yang Y, Wang W, Liu G, Yu Y, Liao M.

Sci Rep. 2016 Jun 28;6:29008. doi: 10.1038/srep29008.

10.

Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies.

Yan Y, Liang H, Li T, Guo S, Li M, Li S, Qin X.

Tumour Biol. 2014 Mar;35(3):2687-92. doi: 10.1007/s13277-013-1354-2. Epub 2014 Jan 5.

11.

FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.

Xu L, Zhou X, Jiang F, Qiu MT, Zhang Z, Yin R, Xu L.

PLoS One. 2013 Sep 23;8(9):e74543. doi: 10.1371/journal.pone.0074543. eCollection 2013.

12.

Association Between WRN Cys1367Arg (T>C) and Cancer Risk: A Meta-analysis.

Wang B, Li G, Sun F, Dong N, Sun Z, Jiang D.

Technol Cancer Res Treat. 2016 Feb;15(1):20-7. doi: 10.1177/1533034614561359. Epub 2014 Dec 2.

PMID:
25468760
13.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
14.
15.
16.

Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.

Qin TT, Chen T, Zhang Q, Du HN, Shu YQ, Luo K, Zhu LJ.

Biomed Pharmacother. 2014 Sep;68(7):905-10. doi: 10.1016/j.biopha.2014.08.006. Epub 2014 Aug 14. Review.

PMID:
25194442
17.

Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.

Elematore I, Gonzalez-Hormazabal P, Reyes JM, Blanco R, Bravo T, Peralta O, Gomez F, Waugh E, Margarit S, Ibañez G, Romero C, Pakomio J, Roizen G, Di Capua GA, Jara L.

Mol Biol Rep. 2014 Jun;41(6):3715-22. doi: 10.1007/s11033-014-3236-0. Epub 2014 Feb 16.

PMID:
24532140
18.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
19.

Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.

Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.

Cerebrovasc Dis. 2012;33(6):558-65. doi: 10.1159/000338781. Epub 2012 Jun 8.

20.

The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.

Wang B, Zhu JM, Fan YG, Feng CC, Chen GM, Chen H, Pan HF, Ye DQ.

Gene. 2013 Sep 15;527(1):95-101. doi: 10.1016/j.gene.2013.05.059. Epub 2013 Jun 4.

PMID:
23747396

Supplemental Content

Support Center